← Back to Search

Procedure

Nerve Block + Physiotherapy for Complex Regional Pain Syndrome

N/A
Waitlist Available
Research Sponsored by Tracy Cupido
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 2 years
Awards & highlights
No Placebo-Only Group

Summary

This trial aims to test a new treatment for adults with Complex Regional Pain Syndrome (CRPS), a severe chronic pain condition. The treatment involves an injection near the shoulder to block pain signals, followed by a program of physical exercises. Researchers hope this combination will be more effective than exercises alone in reducing pain and improving function.

Who is the study for?
This trial is for adults over 18 with Complex Regional Pain Syndrome (CRPS) in the upper extremity who can consent to treatment. It's not suitable for those allergic to local anesthetics or chlorhexidine, have an infection at the injection site, had regional anesthesia for CRPS within 6 months, cannot tolerate anesthesia or physiotherapy, have another pain condition affecting the same limb, or cannot consent.
What is being tested?
The study is testing if a single-shot axillary brachial plexus block combined with physiotherapy is more effective than just physiotherapy alone in treating CRPS. The goal is to see if this new approach improves pain and function better than current treatments.
What are the potential side effects?
Potential side effects may include reactions at the injection site such as pain or infection, allergic reactions to the anesthetic used during nerve block procedures, and typical risks associated with physiotherapy like muscle soreness.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~2 years
This trial's timeline: 3 weeks for screening, Varies for treatment, and 2 years for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Feasibility Assessment
Secondary study objectives
Cost

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Axillary Brachial Plexus Block plus PhysiotherapyExperimental Treatment1 Intervention
Participants who are randomized to the experimental group (EXP arm) will receive a single-shot axillary-approach brachial plexus block with 1.5mg/kg (up to 50mg total) bupivacaine 0.25% at the Kingston Health Sciences Centre Chronic Pain Clinic (KHSC-CPC). Prior to treatment, a blinded third party will perform a baseline physical exam. Under the brachial plexus block, the physiotherapist will provide standard of care, including manual therapy. The patient will then complete a 6-week physiotherapy program, including GMI. Following the 6 week program, a blind observer will repeat the physical exam.
Group II: Physiotherapy aloneActive Control1 Intervention
Participants who are randomized to not receive a block (CON arm) will also have a baseline physical exam performed by a blinded third party. Following baseline data collection, the physiotherapist will provide standard of care, including manual therapy. They will then complete a 6-week home exercise program, including GMI. Following the 6 week program, a blinded observer will repeat the physical exam.

Research Highlights

Information in this section is not a recommendation. We encourage patients to speak with their healthcare team when evaluating any treatment decision.
Mechanism Of Action
Side Effect Profile
Prior Approvals
Other Research
The Brachial Plexus Block (Peripheral Nerve Blockade) works by temporarily interrupting the transmission of pain signals from the affected nerves, which can provide significant pain relief and reduce autonomic and inflammatory changes associated with CRPS. Physiotherapy, on the other hand, aims to improve function and reduce pain through targeted exercises and manual therapy, addressing muscle stiffness, joint mobility, and overall limb function. Combining these treatments can be particularly beneficial for CRPS patients as the nerve block provides immediate pain relief, allowing patients to participate more effectively in physiotherapy, which can lead to long-term improvements in pain management and functional recovery.

Find a Location

Who is running the clinical trial?

Tracy CupidoLead Sponsor
Queen's UniversityLead Sponsor
373 Previous Clinical Trials
124,006 Total Patients Enrolled

Media Library

Brachial Plexus Block (Procedure) Clinical Trial Eligibility Overview. Trial Name: NCT05589259 — N/A
Complex Regional Pain Syndrome Research Study Groups: Axillary Brachial Plexus Block plus Physiotherapy, Physiotherapy alone
Complex Regional Pain Syndrome Clinical Trial 2023: Brachial Plexus Block Highlights & Side Effects. Trial Name: NCT05589259 — N/A
Brachial Plexus Block (Procedure) 2023 Treatment Timeline for Medical Study. Trial Name: NCT05589259 — N/A
~40 spots leftby Sep 2025